DMYD-B:STO
Diamyd Medical AB
SEKÂ 1.01
arrow_downward
-2.32%(-0.024) 1D
Sep 8, 4:12:22 PM GMT+2 · SEK
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DMYD-B...
Open
SEKÂ 1.02
High
SEKÂ 1.03
Low
SEKÂ 1.00
Mkt. cap
153.00M
Avg. vol.
400.23K
Volume
201.56K
52-wk high
SEKÂ 17.88
52-wk low
SEKÂ 0.90
EPS
-SEKÂ 1.98
Shares outstanding
134.00M
No. of employees
44
Open
SEKÂ 1.02
High
SEKÂ 1.03
Low
SEKÂ 1.00
Mkt. cap
153.00M
Avg. vol.
400.23K
Volume
201.56K
52-wk high
SEKÂ 17.88
52-wk low
SEKÂ 0.90
EPS
-SEKÂ 1.98
Shares outstanding
134.00M
No. of employees
44
Profile
Diamyd Medical AB is a small biotechnology company headquartered in Stockholm, Sweden that focuses on immune modifying therapies for type-1 diabetes. The company's investigational drug retogatein is based on a recombinant form of GAD₆₅, one of two human glutamate decarboxylase gene products.
The company is headquartered in Stockholm, and maintains a "biomanufacturing" facility in Umeå which utilizes bacuolavirus-mediated protein expression. Wikipedia
About Diamyd Medical AB